Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
System and method for detecting malicious code executed by virtual machine
Apparatus and method for connection control with media negotiation successful on different media formats
Pre-primed roofing membrane
Touch panel structure and manufacturing method thereof
Controller for soldering iron
Triple-action pest control formulation and method
Signal generator
  Randomly Featured Patents
Location method and panel pressing apparatus
Magnetic holder
Method and apparatus for determinig position and width of metallic material using a pulsed electromagnetic technique
Positive displacement flush syringe
Compliant, solderable input/output bump structures
Module for dispensing controlled patterns of liquid material and a nozzle having an asymmetric liquid discharge orifice
Illumination optical system, exposure device and device manufacturing method
Touch screen control of an adjustable bed
Oxidative process for the preparation of 2-(5H-dibenzo[a,d]cyclohepten-5-on-2-yl)acetic, propionic and butyric acid
Robot vacuum cleaner